埃索美拉唑治疗反流性食管炎的临床观察  

Clinical observation of esomeprazole in the treatment of reflux esophagitis

作　　者：张国联[1] 张宁[1] Zhang Guolian;Zhang Ning(Qingdao City Third People's Hospital of Shandong Province 266041)

机构地区：[1]山东省青岛市第三人民医院,266041

出　　处：《中国社区医师》2016年第31期58-58,60,共2页Chinese Community Doctors

摘　　要：目的:分析埃索美拉唑治疗反流性食管炎的临床效果。方法:收治反流性食管炎患者150例,对所有患者均给予埃索美拉唑治疗,观察患者的临床治疗效果。结果:治疗2周后,患者的临床症状出现明显改善,且治疗4、6周后,其临床症状改善程度越来越明显,第2周、4周、6周的临床治疗有效率分别为60%、80.7%、96%,差异具有统计学意义(P<0.05)。患者无严重不良反应,治疗具有较高的安全性。结论:埃索美拉唑治疗反流性食管炎具有显著临床疗效,能够明显改善反流性食管炎患者的临床症状,且不良反应少。Objective:To analyze the clinical effect of esomeprazole in the treatment of reflux esophagitis.Methods:150 patients with reflux esophagitis were selected.All patients were given esomeprazole treatment.The clinical treatment effect of patients was observed.Results:After 2 weeks of treatment,the clinical symptoms of patients improved obviously.After 4 and 6 weeks after treatment,the improvement degree of clinical symptoms were more and more obvious.The clinical treatment effective rates of 2 weeks,4 weeks,6 weeks were 60% ,80.7% ,96% ,and the difference was statistically significant(P<0.05).The patients had no serious adverse reactions,the treatment had high safety.Conclusion:Esomeprazole in the treatment of reflux esophagitis has a significant clinical curative effect.It can significantly improve the clinical symptoms of reflux esophagitis patients,and it has less adverse reactions.

关 键 词：胃食管反流病 反流性食管炎 埃索美拉唑 

分 类 号：R571[医药卫生—消化系统]